Friday, August 19, 2016

BRIEF-Supernus Pharma receives FDA tentative approval for expanded label of Trokendi XR

* Supernus receives FDA tentative approval for expanded

label of Trokendi XR to include migraine prophylaxis in adults

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)